AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2001 SEP 19 - (NewsRx.com & NewsRx.net) --
Cell Genesys, Inc. (CEGE) has announced that Peter K. Working, PhD, has joined the company in the new position of vice president, research and development.
Working, who served most recently as vice president of analytical and non-clinical sciences and principal scientist at ALZA Corp., brings over 20 years of pharmaceutical research and development experience to Cell Genesys, including 13 years in the biotechnology industry. Working, who will report to Joe Vallner, PhD, president and chief operating officer, was, in the past, a key member of Vallner's team at SEQUUS Pharmaceuticals - a team that successfully developed and launched pharmaceutical products, including the cancer product, Doxil.
Working, 53, has also held various positions with SEQUUS Pharmaceuticals, where he served as vice president of research and development, as well as Genentech, Inc. where he served as a senior toxicologist and head of the Experimental Toxicology Group in the Department of Safety Evaluation. Working holds PhD, MS and BS degrees from the University of California, Davis, and the ...